Tiratricol Use Warning, Recall Alert Subject Of FDA "Talk Paper"
This article was originally published in The Tan Sheet
Executive Summary
FDA is cautioning consumers for a second time against using products containing tiratricol. In a "Talk Paper" issued Nov. 21, the agency cites a series of new recalls, three involving two unapproved new drugs and another relating to an improperly labeled dietary supplement.
You may also be interested in...
FDA Criminal Investigations Of Unapproved Drug Internet Sales Ongoing
FDA's Office of Criminal Investigations has 134 Internet-related investigations under way, 80 of which involve "various types of health fraud or other unapproved drug products" such as GHB. The other 54 cases involve Web sites selling prescription drugs.
Triax Supplement Distribution Barred By Court Order
Dietary supplement marketer Syntrax Innovations is preliminarily barred from making or distributing products containing tiratricol, thyroid hormones or their analogues under a March 3 federal court order.
Triax Weight Loss Supplement Distribution Halted At FDA's Request
The Missouri Department of Health has barred dietary supplement distributor Syntrax Innovations from selling its on-hand supply of a weight loss nutritional supplement due to FDA concerns the product is an unapproved new drug.